Details for Patent: 7,048,906

Title:	Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
Abstract:	Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
Inventor(s):	Lin; Henry C. (Manhattan Beach, CA), Pimentel; Mark (Los Angeles, CA)
Assignee:	Cedars-Sinai Medical Center (Los Angeles, CA)
Filing Date:	Apr 17, 2001
Application Number:	09/837,797
Claims:	1. A method of treating irritable bowel syndrome in a human subject comprising: detecting the presence of small intestinal bacterial overgrowth in the subject; and at least partially eradicating the small intestinal bacterial overgrowth by depriving the bacterial overgrowth of nutrients by causing the subject to consume a diet comprising VIVONEX.RTM.. 2. The method of claim 1, wherein the VIVONEX.RTM. is consumed for at least 3 days. 3. The method of claim 1, wherein the VIVONEX.RTM. is consumed for 10 to 14 days.